However: Larger meta-analyses show no significant increase in risk after adjusting for confounders [25] Incidence appears similar to other diabetes therapies [25] Much of the observed signal likely reflects: Baseline risk (obesity, T2DM) Secondary gallstone disease In summary, pancreatitis in GLP-1 users is a rare and possible complication, but current evidence does not support a substantial increase in risk directly related to GLP-1 agents
Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al
Your pharmacy sends a 20 mg/mL vial for your next refill
Never purchase NAD+ injections directly online without a prescription
3300mg is used in liquid formats for faster absorption, higher endurance needs, and serious fitness users